Download MendeleyStructure Based Design of Potent Selective Inhibitors of Protein Kinase D1 (PKD1).
Feng, J.A., Lee, P., Alaoui, M.H., Barrett, K., Castanedo, G., Godemann, R., McEwan, P., Wang, X., Wu, P., Zhang, Y., Harris, S.F., Staben, S.T.(2019) ACS Med Chem Lett 10: 1260-1265
- PubMed: 31531194
- DOI: https://doi.org/10.1021/acsmedchemlett.8b00658
- Primary Citation of Related Structures:
5W5Q, 6MYN - PubMed Abstract:
We previously disclosed a series of type I 1/2 inhibitors of NF-κB inducing kinase (NIK). Inhibition of NIK by these compounds was found to be strongly dependent on the inclusion and absolute stereochemistry of a propargyl tertiary alcohol as it forms critical hydrogen bonds (H-bonds) with NIK. We report that inhibition of protein kinase D1 (PKD1) by this class of compounds is not dependent on H-bond interactions of this tertiary alcohol. This feature was leveraged in the design of highly selective inhibitors of PKD1 that no longer inhibit NIK. A structure-based hypothesis based on the position and flexibility of the α-C-helix of PKD1 vs NIK is presented.
Organizational Affiliation:
Genentech, 1 DNA way, South San Francisco, California 94080, United States.
